0001179110-22-001943.txt : 20220302
0001179110-22-001943.hdr.sgml : 20220302
20220302175103
ACCESSION NUMBER: 0001179110-22-001943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOOVER R DAVID
CENTRAL INDEX KEY: 0001186033
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 22705457
MAIL ADDRESS:
STREET 1: C/O EDGEWELL PERSONAL CARE COMPANY
STREET 2: 1350 TIMBERLAKE MANOR PARKWAY
CITY: CHESTERFIELD
STATE: MO
ZIP: 63017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
FORM 4 -
X0306
4
2022-02-28
0
0001739104
Elanco Animal Health Inc
ELAN
0001186033
HOOVER R DAVID
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
1
0
0
0
See Remarks
Common Stock
2022-03-01
4
P
0
5000
28.6645
A
110000
I
Revocable Trust
Common Stock
2022-03-02
4
P
0
5000
29.00
A
115000
I
Revocable Trust
Common Stock
39267
D
Common Stock
15920
I
Suzanne A. Hoover Revocable Trust
Deferred Stock Units
2022-02-28
4
A
0
375.4548
28.41
A
Common Stock
375.4548
20395.336
D
Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 1, 2022 with purchase prices ranging from $28.43 to $28.899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 2, 2022 with purchase prices ranging from $28.88 to $29.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022.
Chairman of the Elanco Board of Directors
/s/ Collin G. Smyser, as Attorney-in-Fact for R. David Hoover
2022-03-02